Explore Teva in the UK
We are all in for better health
We at Teva are giving it our all for better health – better health for patients, communities and healthcare systems, better health for Teva employees globally, and better health for our planet by working sustainably.
You might be surprised to learn that we’ve been supplying medicines in the UK since the 1930s, making us older than the NHS!
Enabling access to high quality medicines and treatment options
A new kind of pharmaceutical company
Today, Teva aims to be a new kind of pharmaceutical company.
One liberated from the traditional definition of a generic medicines company. A company with a category-defying portfolio, harnessing our generics expertise and stepping up innovation, continuing the momentum behind the discovery, delivery and expanded development of modern medicine.
To healthcare professionals, patients, caregivers and families, we commit to push the boundaries to help deliver quality medicine wherever it is needed, discover life changing treatments and strive forward through scientific innovation.
Because when it comes to health, good is not enough for us.
THIS is the Teva legacy – to be stronger, bolder and simpler in the way we operate and relentless in our growth, by understanding what’s next – in science, for patients, people and society.
We are all in for better health
Moving forward together with science the treats, inspired by the people we serve.
We are Teva.
At Teva, we’re a category-defying company
At Teva we believe that everyone should have access to quality medicine that helps manage disease, fights infection, or simply improves overall health.
From in-house innovation to strategic partnerships, we are persistently discovering, developing and delivering both generic and innovative medicines.
We are not defined by any one label.
Instead, our legacy in high-quality generics enables us to leverage our capabilities to bring forward complex generics and biosimilars at scale to create more value for patients and healthcare systems, and an improved health impact.
We maximise pivotal solutions that lead to better health for our patients and a stronger company for our people by delivering in the short-term to drive long-term stability.
Migraine
Chronic and episodic migraine
Oncology & Pain
Pain management and cancer therapies
We play an important role in delivering value to healthcare systems and economies around the world
The scale of production and accessible price of our products help to limit rising healthcare costs and improve patient health outcomes.
We also invest hundreds of millions of pounds every year to enable our scientists to develop specialty and biopharmaceutical treatments that aim to improve patients’ health and increase access to medicines.
Delivering value to the NHS
Our 90-year UK history, together with our global reach and legacy in high-quality generics, enable us to leverage our capabilities to bring forward complex generics and biosimilars at scale, helping support more patients while creating more value for the NHS.
We are strengthening our generic medicines portfolio by focusing our capabilities on complex drug design – in both generics and biosimilars – and leading-edge manufacturing to increase efficiency and bring the most value to both patients and the health service, while creating more space for innovative research.
And we’re proud to be able to work closely with the NHS to bring solutions to market to make sure that patients have access to affordable treatment options both now and in the future.
Generic medicines bring significant savings to the NHS medicines bill – estimates are that generic medicines save the NHS around £16 billion† every year, in England and Wales, compared to the cost if their branded equivalents had been dispensed. This frees up valuable NHS resources to be directed to where patients need them most.
As one of the leading generic medicines suppliers in the UK, Teva was responsible for £2.4 billion of these savings in 2023.‡
The chances are, someone you know is living a healthier life, because of our medicines – after all, we are one of the largest suppliers of prescription medicines to the NHS¶,§
Proud to be positively impacting the UK economy
Teva is a major employer in the UK with over a thousand highly skilled colleagues working across our research, manufacturing and commercial operations
As an employer and a manufacturer, Teva creates jobs and contributes to economic output. Beyond direct expenditures, Teva's spending initiates a series of income creation, spending and re-spending that support other jobs and contribute to additional Gross Domestic Product (GDP) and overall economic output.
In 2023, Teva’s economic activities in the UK directly contributed £211 million to British gross domestic product, supported almost 5,000 full time jobs, and provided labour income of £62 million.¥
Investing in the UK
We have sites across the UK with extensive operations that span all aspects of bringing medicines to market. They are all working together to provide high-quality medicines to millions of patients - not just in the UK, but worldwide.
Manufacturing and R&D
Runcorn, Cheshire is home to our manufacturing facility for sterile liquid products, which are distributed to countries around the world. It’s also the base for two research and development centres developing sterile drug products and sterile device technology.
Our Larne site in Northern Ireland is a research and development facility focusing on branded and generic developments in medical implants and devices.
Commercial
Our UK commercial headquarters and hi-tech logistics centre is based in Castleford, in the heart of West Yorkshire.
Our site in Harlow, Essex, is home to many of our specialist teams, including Sales and Marketing, Medical, Regulatory Affairs and Legal. It’s a Centre of Excellence for Regulatory Affairs within Teva, with teams covering both European and global licensing for medicines and over-the-counter (OTC) products.
Our field-based medical and commercial teams working with customers right across the UK.
Leveraging our global size and strength
Teva is a global pharmaceutical leader with a strong legacy in generics, a category-defying portfolio, an appetite for innovation, a culture of innovation and a boundary-pushing approach to supporting better health outcomes. All of these bring considerable benefits to patients in the UK
We are continually expanding our range of medicines, devices, services and partnerships to better meet the needs of UK patients and to offer increased choice to healthcare professionals.
We produce approximately 76 billion tablets and capsules a year through our 49 manufacturing facilities in 26 countries.*
Improving the lives of patients
And that means all across the UK, people you probably know are living a healthier life because of our medicines.
Footnotes
* Teva Global Operations - Internal Data Sources - As at August 2024
** We estimate that 200 million patients across six continents take one of our products every day - Internal analyses conducted by Teva's Global Insights, Access & Technologies Department estimating number of Teva consumers.
† British Generics Manufacturers Association https://www.britishgenerics.co.uk/about-generics.html - Accessed August 2024
‡ Teva UK - Data on file
¶ Teva UK - Data on file
§ Teva UK - Data on file
¥ Teva Economic Impact Report - Matrix Global Advisors estimate of Teva’s Macroeconomic Impact in the UK in 2023
Creating a healthy future
We are dedicated to promoting health and increasing access to treatment for patients
Fast track your career
We can offer you the chance to make a real difference in people's lives and add value to your career